Collectively, these results underscore that delivery of tethered mIL-12 via pMHC-targeted viruses affects both adaptive and innate tumor-infiltrating immune cells, driving expansion of on-target cells and initiating a broader IFN-γ–based immune response within the tumor microenvironment. This evidence concerns the gene IFNG and neoplasm.